[Met5,Arg6,Phe7] Enkephalin

CAS No. 73024-95-0

[Met5,Arg6,Phe7] Enkephalin( ——— )

Catalog No. M41140 CAS No. 73024-95-0

Met-Enkephalin-Arg-Phe is a naturally occurring heptapeptide with analgesic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Met5,Arg6,Phe7] Enkephalin
  • Note
    Research use only, not for human use.
  • Brief Description
    Met-Enkephalin-Arg-Phe is a naturally occurring heptapeptide with analgesic activity.
  • Description
    Met-Enkephalin-Arg-Phe is a naturally occurring heptapeptide with analgesic activity.
  • In Vitro
    ———
  • In Vivo
    Animal Model:Male Swiss Webster mice Dosage:10-100 nmol/mouse Administration:Intracerebralventricular injection, once Result:Produced a dose-related inhibition of the tail-flick response. The effects peaked at 2-4 min and were dissipated by 10 min. The EC50 was 38.5 nmol/mouse.
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    73024-95-0
  • Formula Weight
    877.04
  • Molecular Formula
    C42H56N10O9S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Inturrisi CE, et al. Analgesic activity of the naturally occurring heptapeptide Metenkephalin-Arg6-Phe7. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5512-4.?
molnova catalog
related products
  • Lumiracoxib

    Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. Phase 4.

  • Cinnamtannin A2

    Cinnamtannin A2, a tetrameric procyanidin, enhances GLP-1 and insulin secretion in mice while also upregulating the expression of corticotrophin releasing hormone.

  • Ibiglustat

    An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access.